Obesity and pregnancy

Obesity and Pregnancy

Volumn , Issue , 2010, Pages 1-184

  Briese, Volker ^a   Voigt, Manfred ^b   Straube, Sebastian ^c  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b Institute for Perinatal Auxology   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892344110     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (356)

1. Galtier-Dereure F, Montpeyroux F, Boulot P, Bringer J, Jaffiol C. Weight excess before pregnancy: complications and cost. Int. J. Obes. Relat. Metab. Disord. 1995; 19: 443-8.
2. Galtier-Dereure F, Boegner C, Bringer J. Obesity and pregnancy: complications and cost. Am. J. Clin. Nutr. 2000; 71 (5 Suppl): 1242S-8S.
3. Soens MA, Birnbach DJ, Ranasinghe JS, van Zundert A. Obstetric anesthesia for the obese and morbidly obese patient: an ounce of prevention is worth more than a pound of treatment. Acta Anaesthesiol. Scand. 2008; 52: 6-19.
4. Voigt M, Straube S, Zygmunt M, Krafczyk B, Schneider KT, Briese V. Obesity and pregnancy-a risk profile. Z. Geburtshilfe Neonatol. 2008a; 212: 201-5.
5. Voigt M, Zygmunt M, Henrich W, Straube S, Carstensen M, Briese V. Analysis of subgroup of pregnant women in Germany. 16th communication: morbid obesity: pregnancy risks, birth risks and status of the newborn. Geburtsh Frauenheilk. 2008b; 68: 794-800.
6. Zain MM, Norman RJ. Impact of obesity on female fertility and fertility treatment. Womens Health (Lond Engl). 2008; 4: 183-94.
7. Leddy MA, Power ML, Schulkin J. The impact of maternal obesity on maternal and fetal health. Rev. Obstet. Gynecol. 2008; 1: 170-8.
8. World Health Organization (WHO) Website: http://www.who.int/bmi/index.jsp? introPage= intro_3.html, accessed 08-04-2009.
9. National Heart, Lung and Blood Institute Website: http://www.nhlbi.nih.gov/guidelines/obesity/e_txtbk/txgd/4142.htm, accessed 08-04-2009.
10. Balkau B, Deanfield JE, Després JP, Bassand JP, Fox KA, Smith SC Jr, Barter P, Tan CE, Van Gaal L, Wittchen HU, Massien C, Haffner SM. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation. 2007; 116: 1942-51.
11. Beydoun MA, Wang Y. Gender-ethnic Disparity in BMI and Waist Circumference Distribution Shifts in US Adults. Obesity (Silver Spring). 2009; 17: 169-76.
12. Blissing S, Roloff R, Rehn M, Frambach T, Dietl J. Prävalenz von Übergewicht und Adipositas bei Schwangeren an der Universitäts-Frauenklinik Würzburg und resultierende perinatale Ergebnisse-ein Vergleich zwischen 1980 und 2005. Geburtsh Frauenheilk. 2008; 68: 159-164
13. Hauner H, Bramlage P, Lösch C, Steinhagen-Thiessen E, Schunkert H, Wasem J, Jöckel KH, Moebus S. Prevalence of obesity in primary care using different anthropometric measures--results of the German Metabolic and Cardiovascular Risk Project (GEMCAS). BMC Public Health. 2008; 8: 282.
14. Vahratian A. Prevalence of Overweight and Obesity Among Women of Childbearing Age: Results from the 2002 National Survey of Family Growth. Matern. Child Health J. 2009; 13: 268-73.
15. Voigt M, Straube S, Zygmunt M, Krafczyk B, Schneider KT, Briese V. Obesity and pregnancy-a risk profile. Z. Geburtshilfe Neonatol. 2008; 212: 201-5.
16. Barker DJ. The fetal and infant origins of adult disease. BMJ. 1990; 301: 1111.
17. Dietz WH. Periods of risk in childhood for the development of adult obesity-what do we need to learn? J. Nutr. 1997; 127: 1884S-1886S.
18. Fasting MH, Oken E, Mantzoros CS, Rich-Edwards JW, Majzoub JA, Kleinman K, Rifas-Shiman SL, Vik T, Gillman MW. Maternal levels of corticotrophin-releasing hormone during pregnancy in relation to adiponectin and leptin in early childhood. J. Clin. Endocrinol. Metab. 2009; 94: 1409-15.
19. Lawlor DA, Smith GD, O'Callaghan M, Alati R, Mamun AA, Williams GM, Najman JM. Epidemiologic evidence for the fetal overnutrition hypothesis: findings from the mater-university study of pregnancy and its outcomes. Am. J. Epidemiol. 2007; 165: 418-424.
20. Leddy MA, Power ML, Schulkin J. The impact of maternal obesity on maternal and fetal health. Rev. Obstet. Gynecol. 2008; 1: 170-178.
21. Melnik BC: Milk-The promoter of chronic Western diseases. Med. Hypotheses. 2009; 72: 631-9.
22. Oken E, Taveras EM, Kleinman KP, Rich-Edwards JW, Gillman MW. Gestational weight gain and child adiposity at age 3 years. Am. J. Obstet. Gynecol. 2007; 196: 322.e1-8.
23. Simmons R. Perinatal programming of obesity. Semin. Perinatol. 2008; 32: 371-4.
24. Straube S, Voigt M, Briese V, Schneider KT, Voigt M. Weight gain in pregnancy according to maternal height and weight. J. Perinat. Med. 2008; 36: 405-12.
25. Walker CD, Naef L, d'Asti E, Long H, Xu Z, Moreau A, Azeddine B. Perinatal maternal fat intake affects metabolism and hippocampal function in the offspring: a potential role for leptin. Ann. N.Y. Acad. Sci. 2008; 1144: 189-202.
26. Antuna-Puente B, Feve B, Fellahi S, Bastard JP. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab. 2008; 34: 2-11.
27. Cannon CP. Obesity-related cardiometabolic complications. Clin. Cornerstone. 2008; 9: 11-22.
28. Daniele A, Cammarata R, Pasanisi F, Finelli C, Salvatori G, Calcagno G, Bracale R, Labruna G, Nardelli C, Buono P, Sacchetti L, Contaldo F, Oriani G. Molecular Analysis of the Adiponectin Gene in Severely Obese Patients from Southern Italy. Ann. Nutr. Metab. 2008; 53: 155-161.
29. Jocken JW, Blaak EE: Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity. Physiol. Behav. 2008; 94: 219-30.
30. Fasshauer M, Waldeyer T, Seeger J, Schrey S, Ebert T, Kratzsch J, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H. Serum levels of the adipokine visfatin are increased in pre-eclampsia. Clin. Endocrinol. (Oxf). 2008a; 69: 69-73.
31. Fasshauer M, Seeger J, Waldeyer T, Schrey S, Ebert T, Kratzsch J, Lössner U, Blüher M, Stumvoll M, Faber R, Stepan H. Serum levels of the adipokine adipocyte fatty acid-binding protein are increased in preeclampsia. Am. J. Hypertens. 2008b; 21: 582-6.
32. Mazaki-Tovi S, Romero R, Kusanovic JP, Vaisbuch E, Erez O, Than NG, Chaiworapongsa T, Nhan-Chang CL, Pacora P, Gotsch F, Yeo L, Kim SK, Edwin SS, Hassan SS, Mittal P. Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight. J. Perinat. Med. 2009; 37: 218-31.
33. Mumtaz F, Memon AR, Yousfani S, Tahir SM, Khushk I, Memon M, Memon A. Role of serum leptin level as a marker of severity of pre-eclampsia. J. Ayub. Med. Coll. Abbottabad. 2008; 20: 13-5.
34. Rasouli N, Kern PA. Adipocytokines and the metabolic complications of obesity. J. Clin. Endocrinol. Metab. 2008; 93(11 Suppl 1): S64-73.
35. Skurk T, Kolb H, Müller-Scholze S, Röhrig K, Hauner H, Herder C. The proatherogenic cytokine interleukin-18 is secreted by human adipocytes. Eur. J. Endocrinol. 2005; 152: 863-868.
36. Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J. Clin. Endocrinol. Metab. 2007; 92: 1023-1033.
37. Skurk T, Mack I, Kempf K, Kolb H, Hauner H, Herder C. Expression and Secretion of RANTES (CCL5) in Human Adipocytes in Response to Immunological Stimuli and Hypoxia. Horm. Metab. Res. 2009a; 41: 183-9.
38. Skurk T, Alberti-Huber C, Hauner H. Effect of Conditioned Media from Mature Human Adipocytes on Insulin-stimulated Akt/PKB Phosphorylation in Human Skeletal Muscle Cells: Role of BMI and Fat Cell Size. Horm. Metab. Res. 2009b; 41: 190-6.
39. Van Harmelen V, Reynisdottir S, Eriksson P, Thörne A, Hoffstedt J, Lönnqvist F, Arner P. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes. 1998; 47: 913-7.
40. Vázquez-Vela ME, Torres N, Tovar AR. White adipose tissue as endocrine organ and its role in obesity. Arch. Med. Res. 2008; 39: 715-728.
41. Yan QW, Yang Q, Mody N, Graham TE, Hsu CH, Xu Z, Houstis NE, Kahn BB, Rosen ED. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes. 2007; 56: 2533-2540.
42. Abdollahi M, Cushman M, Rosendaal FR. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb. Haemost. 2003; 89: 493-498.
43. Allais G, Gabellari IC, De Lorenzo C, Mana O, Benedetto C. Oral contraceptives in migraine. Expert Rev Neurother. 2009; 9: 391-393.
44. Bhathena RK. Therapeutic options in the polycystic ovary syndrome. J. Obstet. Gynaecol. 2007; 27: 123-129.
45. Brunner Huber LR, Hogue CJ, Stein AD, Drews C, Zieman M. Body mass index and risk for oral contraceptive failure: a case-cohort study in South Carolina. Ann. Epidemiol. 2006; 16: 637-643.
46. Brunner Huber LR, Toth JL. Obesity and contraceptive failure: findings from the 2002 National Survey of Family Growth. Am. J. Epidemiol. 2007; 166: 1306-1311.
47. Chuang CH, Chase GA, Bensyl DM, Welsman CS. Contraceptive use by diabetic and obese women. Womens Health Issues. 2005; 15: 167-173.
48. Clark MK, Dillon JS, Sowers M, Nichols S. Weight, fat mass, and central distribution of fat increases when women use depot-medroxyprogesteron acetate for contraception. Int. J. Obes. (Lond). 2005; 29: 1252-1258.
49. Cushman M, Kuller LH, Prentice R, Rodabough RJ, Psaty BM, Stafford RS, Sidney S, Rosendaal FR. Estrogen and progestin and risk of venous thrombosis. JAMA. 2004; 292: 1573-1580.
50. Nelson SM, Fleming RF. The preconceptual contraception paradigm: obesity and infertility. Hum. Reprod. 2007; 22: 912-915.
51. Patel JA, Colella JJ, Esaka E, Patel NA, Thomas RL. Improvement in infertility and pregnancy after weight loss surgery. Med. Clin. North Am. 2007; 91: 515-528.
52. Pitts SA, Emans SJ. Controversies in contraception. Curr. Opin. Pediatr. 2008; 20: 383-389.
53. Pomp ER, le Cessie S, Rosendaal FR, Doggen CJ. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br. J. Haematol. 2007; 139: 289-296.
54. Rosenfield RL. What every physician should know about polycystic ovary syndrome. Dermatol. Ther. 2008; 21: 354-36.
55. Yahratian A, Barber JS, Lawrence JM, Kim C. Family Planning Practices among Women with Diabetes and Overweight and Obese Women in the 2002 National Survey for Family Growth. Diabetes Care. 2009; 32: 1026-31.
56. Balen AH, Anderson RA. Impact of obesity on female reproductive health: British fertility society, Policy and Practice Guidelines. Hum. Fertil. (Camb). 2007; 10: 195-206.
57. ESHRE Capri Workshop Group. Nutrition and reproduction in women. Hum. Reprod. Update. 2006; 12: 193-207.
58. Fedorcsák P, Dale PO, Storeng R, Ertzeid G, Bjercke S, Oldereid N, Omland AK, Abyholm T, Tanbo T. Impact of overweight and underweight on assisted reproduction treatment. Hum. Reprod. 2004; 19: 2523-2528.
59. Jain A, Polotsky AJ, Rochester D, Berga SL, Loucks T, Zeitlian G, Gibbs K, Polotsky HN, Feng S, Isaac B, Santoro N. Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women. J. Clin. Endocrinol. Metab. 2007; 92: 2468-2473.
60. Ku SY, Kim SD, Jee BC, Suh CS, Choi YM, Kim JG, Moon SY, Kim SH. Clinical efficacy of body mass index as predictor of in vitro fertilisation and embryo transfer outcomes. J. Korean Med. Sci. 2006; 2: 300-303.
61. Levens ED, Skarulis MC. Assessing the role of endometrial alteration among obese patients undergoing assisted reproduction. Fertil Steril. 2008; 89: 1606-1608.
62. Mathur R, Alexander CJ, Yano J, Trivax B, Azziz R. Use of metformin in polycystic ovary syndrome. Am. J. Obstet. Gynecol. 2008; 199: 596-609.
63. Mitchell M, Armstrong DT, Robker RL, Norman RJ. Adipokines: implications for female fertility and obesity. Reproduction. 2005; 130: 583-597.
64. Nelson SM, Fleming RF. The preconceptual contraception paradigm: obesity and infertility. Hum. Reprod. 2007; 22: 912-915.
65. Parazzini F, Cipriani S, Bianchi S, Gotsch F, Zanconato G, Fedele L. Risk factors for deep endometriosis: a comparison with pelvic and ovarian endometriosis. Fertil Steril. 2008; 90: 174-179.
66. Pasquali R. Obesity, fat distribution and infertility. Maturitas. 2006; 54:363-71.
67. Pasquali R, Patton L, Gambineri A. Obesity and infertility. Curr. Opin. Endocrinol. Diabetes Obes. 2007; 14: 482-7.
68. Tian L, Shen H, Lu Q, Norman RJ, Wang J. Insulin resistance increases the risk of spontaneous abortion after assisted reproduction technology treatment. J. Clin. Endocrinol. Metab. 2007;92:1430-3.
69. Van der Steeg JW, Steures P, Eijkemans MJ, Habbema JD, Hompes PG, Burggraaff JM, Oosterhuis GJ, Bossuyt PM, van der Veen F, Mol BW. Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum. Reprod. 2008; 23: 324-328.
70. Zain MM, Norman RJ. Impact of obesity on female fertility and fertility treatment. Womens Health. (London Engl). 2008; 4: 183-194.
71. Botto LD, Olney RS, Erickson JD. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am. J. Med. Genet. C Semin. Med. Genet. 2004; 125C: 12-21.
72. Cengiz B, Söylemez F, Oztürk E, Cavdar AO. Serum zinc, selenium, copper, and lead levels in women with second-trimester induced abortion resulting from neural tube defects: a preliminary study. Biol. Trace Elem. Res. 2004; 97: 225-235.
73. Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 1992; 327: 1832-5.
74. Hernandez-Diaz S, Werler MM, Louik C, Mitchell AA. Risk of gestational hypertension in relation to folic acid supplementation during pregnancy. Am. J. Epidemiol. 2002; 156: 806-812.
75. Inskip HM, Crozier SR, Godfrey KM, Borland SE, Cooper C, Robinson SM; Southampton Women's Survey Study Group. Women's compliance with nutrition and lifestyle recommendations before pregnancy: general population cohort study. BMJ. 2009; 338:b481.
76. Kind A, Surbek D. Präkonzeptionelle Beratung und Prävention. Gynäkologie. 2008; 3: 6-11.
77. McElhatton PR, Bateman DN, Evans C, Pughe KR, Thomas SH. Congenital anomalies after prenatal ecstasy exposure. Lancet. 1999; 354: 1441-1442.
78. Rasmussen SA, Chu SY, Kim SY, Schmid CH, Lau J. Maternal obesity and the risk of neural tube defects: a metaanalysis. Am. J. Obstet. Gynecol. 2008; 198: 611-619.
79. Ray JG, Thompson MD, Vermeulen MJ, Meier C, Wyatt PR, Wong PY, Summers AM, Farrell SA, Cole DE. Metabolic syndrome features and risk for neural tube defects. BMC Pregnancy Childbirth. 2007; 19: 21.
80. Shaw GM, Lammer EJ, Wasserman CR, O'Malley CD, Tolarova MM. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet. 1995; 346: 393-6.
81. Colquitt J, Clegg A, Loveman E, Royle P, Sidhu M, Colquitt J. Surgery for morbid obesity. Cochrane Database Syst. Rev. 2005; 4: CD003641.
82. Gardner CD, Kiazand A, Alhassan S, Kim S, Stafford RS, Balise RR, Kraemer HC, King AC. Comparison of the Atkins, Zone, Ornish, and LEARN Diets for Change in Weight and Related Risk Factors Among Overweight Premenopausal Women. JAMA. 2007; 297: 969-977.
83. Guelinckx I, Devlieger R, Vansant G. Reproductive outcome after bariatric surgery: a critical review. Hum. Reprod. Update. 2009; 15: 189-201.
84. Jasaitis Y, Sergent F, Bridoux V, Paquet M, Marpeau L, Ténière P. [Management of pregnancies after adjustable gastric banding] J. Gynecol. Obstet. Biol. Reprod. (Paris). 2007; 36: 764-9.
85. Rubio MA, Gargallo M, Isabel Millán A, Moreno B. Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant. Public Health Nutr. 2007; 10(10A):1200-5.
86. Wolf AM, Beisiegel U.The effect of loss of excess weight on the metabolic risk factors after bariatric surgery in morbidly and super-obese patients. Obes. Surg. 2007; 17: 910-9.
87. Lim JH, Kim SY, Park SY, Yang JH, Kim MY, Ryu HM. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors. Obstet. Gynecol. 2008; 111: 1403-1409.
88. Tiller R, Friedrich A, Tiller G. Teenagerschwangerschaften-Morbidität und Mortalität von Neugeborenen jugendlicher Mütter der Geburtsjahrgänge 1998-2005. Gyn. 2008; 421-425.
89. Wisser J. Evidenzbasiertes Wissen in der Geburtshilfe. Entscheidungen nach Cochrane und Co. Gynäkologie und Geburtshilfe. 2008; 8:33-36.
90. Woodward PJ, Kennedy A, Sohaey R, Byrne JLB, Oh KY, Puchalski MD. Diagnostic Imaging Obstetrics. Amyrsis Inc, Salt Lake city, Utah, 2005.
91. Bodnar LM, Catov JM, Roberts JM, Simhan HN. Prepregnancy obesity predicts poor vitamin D status in mothers and their neonates. J. Nutr. 2007; 137: 2437-2442.
92. Briese V, Kirschner W, Friese K. Ernährungsberatung: Ernährungsdefizite in der Schwangerschaft. Frauenarzt. 2001; 42: 1220-1228.
93. Holick MF.Vitamin D deficiency. N. Engl. J. Med. 2007; 357: 266-81.
94. Straube S, Voigt M, Briese V, Schneider KT, Voigt M. Weight gain in pregnancy according to maternal height and weight. J. Perinat. Med. 2008; 36: 405-12.
95. Voigt M, Straube S, Zygmunt M, Krafczyk B, Schneider KT, Briese V. Obesity and pregnancy-a risk profile. Z. Geburtshilfe Neonatol. 2008; 212: 201-5.
96. Willet WC, Sacks F, Trichopoulou A. Mediterranean diet pyramid: a cultural model for healthy eating. Am. J. Clin. Nutr. 1995; 61(6 Suppl): 1402S-1406S.
97. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am. J. Clin. Nutr. 2000; 72: 690-693.
98. Bagos PG. Plasminogen activator inhibitor-1 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome. Mol. Hum. Reprod. 2009; 15: 19-26.
99. Carmina E, Orio F, Palomba S, Longo RA, Cascella T, Colao A, Lombardi G, Rini GB, Lobo RA. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am. J. Med. 2006; 119: 356.e1-6.
100. Cocksedge KA, Li TC, Saravelos SH, Metwally M. A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage. Reprod. Biomed. Online. 2008; 17: 151-60.
101. Franks S, McCarthy MI, Harsy K. Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Int. J. Androl. 2006; 29: 278-285.
102. Jungheim ES, Lanzendorf SE, Odem RR, Moley KH, Chang AS, Ratts VS. Morbid obesity is associated with lower clinical pregnancy rates after in vitro fertilization in women with polycystic ovary syndrome. Fertil Steril. 2009; 92: 256-61.
103. Mulders AG, ten Kate-Booij M, Pal R, De Kruif M, Nekrui L, Oostra BA, Fauser BC, Laven IS. Influence of oral contraceptive pills an phenotype expression in women with polycystic ovary syndrome. Reprod. Biomed. Online. 2005; 11: 690-696.
104. Tarlatzis BC, Fauser BC, Legro RS, Norman RJ, Hoeger K, Pasquali R, Franks S, Messinis IE, Casper RF, Homburg JN, Lobo R, Rebar RW, Fleming R, Carr BR, Bouchard P, Chang J, Hugues JN, Azziz R, Kolibianakis EM, Griesinger G, Diedrich K, Balen A, Farquhar C, Devroey P, Ho PC, Collins J, Goulis DG, Eijkemans R, Crosignani PG, DeCherney A, Van Steirteghem A. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum. Reprod. 2008; 23: 462-77.
105. Artham SM, Lavie CJ, Milani RV, Ventura HO. The obesity paradox: impact of obesity on the prevalence and prognosis of cardiovascular diseases. Postgrad. Med. 2008; 120: 34-41.
106. Balkau B, Deanfield JE, Després JP, Bassand JP, Fox KA, Smith SC Jr, Barter P, Tan CE, Van Gaal L, Wittchen HU, Massien C, Haffner SM. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation. 2007; 116: 1942-51.
107. Copertaro A, Bracci M, Barbaresi M, Santarelli L. Role of waist cirumference in the diagnosis of metabolic syndrome and assessment of cardiovascular risk in shift workers. Med. Lav. 2008; 99: 444-53.
108. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004; 109: 433-8.
109. Hu G, Tuomilehto J, Silventoinen K, Sarti C, Männistö S, Jousilahti P. Body mass index, waist circumference, and waist-hip ratio on the risk of total and type-specific stroke. Arch. Intern. Med. 2007; 167: 1420-7.
110. Lawlor DA, Lean M, Sattar N. ABC of obesity: obesity and vascular disease. BMJ. 2006; 333: 1060-1063.
111. McCarthy HD. Body fat measurements in children as predictors for the metabolic syndrome: focus on waist circumference. Proc. Nutr. Soc. 2006; 65: 385-92.
112. Moebus S, Hanisch JU, Aidelsburger P, Bramlage P, Wasem J, Jöckel KH: Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc. Diabetol. 2007; 6: 22.
113. Wardle J, Carnell S, Haworth CMA, Plomin R: Evidence for a strong genetic influence on childhood adiposity despite the force oft the obesogenic environment. Am. J. Clin. Nutr. 2008; 87: 398-404.
114. Zain MM, Norman RJ. Impact of obesity on female fertility and fertility treatment. Womens Health. (Lond Engl). 2008; 4: 183-94.
115. Chait A, Brunzell JD. Acquired hyperlipidemia (secondary dyslipoproteinemias). Endocrinol. Metab. Clin. North Am. 1990; 19: 259-78.
116. Dörner K. Clinical Chemistry and Hematology. Georg Thieme Verlag, Stuttgart 2006; 158-165.
117. Ingelsson E, Massaro JM, Sutherland P, Jacques PF, Levy D, D'Agostino RB, Vasan RS, Robins SJ. Contemporary trends in dyslipidemia in the Framingham Heart Study. Arch. Intern. Med. 2009; 169: 279-286.
118. Liquori A, D'Armiento FP, Palagiano A, Palinski W, Napoli C. Maternal C-reactive protein and developmental programming of atherosclerosis. Am. J. Obstet. Gynecol. 2008; 198: 281.e1-5.
119. Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat. Clin. Pract. Endocrinol. Metab. 2009; 5: 150-159.
120. Nguyen NT, Magno CP, Lane KT, Hinojosa MW, Lane JS. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J. Am. Coll. Surg. 2008; 207: 928-934.
121. Putaala J, Metso AJ, Metso TM, Konkola N, Kraemer Y, Haapaniemi E, Kaste M, Tatlisumak T. Analysis of 1008 Consecutive Patients Aged 15 to 49 With First-Ever Ischemic Stroke. The Helsinki Young Stroke Registry. Stroke. 2009; 40: 1195-203.
122. Tsimihoimos V, Dounousi E, Siamopoulos KC. Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment. Am. J. Nephrol. 2008; 28: 958-973.
123. Berg CJ, Park ER, Chang Y, Rigotti NA. Is concern about post-cessation weight gain a barrier to smoking cessation among pregnant women? Nicotine Tob. Res. 2008; 10: 1159-1163.
124. Berlin I. Endocrine and metabolic effects of smoking cessation. Curr. Med. Res. Opin. 2009; 25: 527-534.
125. Chelland Campbell S, Moffatt RJ, Stamford BA. Smoking and smoking cessation--the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis. 2008; 201: 225-35.
126. Conde-Agudelo A, Althabe F, Belizan J, Kafury-Goeta AC. Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am. J. Obstet. Gynecol. 1999; 181: 1026-1035.
127. Heatherton TF, Koziowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. Brit. J. Addict. 1991; 86: 1119-27.
128. Magee BD, Hattis D, Kivel NM. Role of smoking in low birth weight. J. Reprod. Med. 2004; 49: 23-27.
129. Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am. J. Obstet. Gynecol. 2006; 195: 40-49.
130. Ness RB, Zhang J, Bass D, Klebanoff MA. Interactions between Smoking and Weight in Pregnancies Complicated by Preeclampsia and Small-for-Gestational Age. Am. J. Epidemiol. 2008; 168: 427-433.
131. Newman MG, Lindsay MK, Graves W. Cigarette smoking and pre-eclampsia: their association and effects on clinical outcome. J. Matern. Fetal. Med. 2001; 10: 166-170.
132. Santos IS, Barros AJ, Matijasevich A, Tomasi E, Medeiros RS, Domingues MR, Bertoldi AD, Barros FC, Victora CG. Mothers and their pregnancies: a comparison of three population-based cohorts in Southern Brazil. Cad. Saude Publica. 2008; 24 Suppl 3: S381-S389.
133. Somm E, Schwitzgebel VM, Vauthay DM, Camm EJ, Chen CY, Giacobino JP, Sizonenko SV, Aubert ML, Hüppi PS. Prenatal nicotine exposure alters early pancreatic islet and adipose tissue development with consequences on the control of body weight and glucose metabolism later in life. Endocrinology. 2008; 149: 6289-6299.
134. Prospective Studies Collaboration, Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R. Collaborators (157) Body-mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009; 373: 1083-96.
135. Van der Vaart H, Postma DS, Timens W, ten Hacken NH. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax. 2004; 59: 713-721.
136. Abrams B, Altman S, Pickett K. Pregnancy weight gain: still controversial. Am. J. Clin. Nutr. 2000; 71 (Suppl.): 1233-1241.
137. Becker S, Fedtke M, Felun T, Wallwiener D, Aydeniz B. Entwicklung des Körpergewichts vor, während und ein Jahr nach der Schwangerschaft. Geburtsh Frauenheilk. 2004; 64: 706-710.
138. Cedergren M. Effects of gestational weight gain and body mass index on obstetric outcome in Sweden. Int. J. Gynaecol. Obstet. 2006; 93: 269-274.
139. Grabow D, Straube W. Über den Einfluss mütterlicher konstitutioneller Faktoren und der Gewichtszunahme während der Schwangerschaft auf die Neugeborenenmaße Gewicht und Länge. Zbl. Gynakol. 1987; 109: 681-692.
140. Hediger ML, Scholl TO, Belsky DH, Ances IG, Salmon RW. Patterns of weight gain in adolescent pregnancy: effects on birth weight and preterm delivery. Obstet. Gynecol. 1989; 74: 6-12.
141. Johnson WC, Yancey MK. A critique of the new recommendation for weight gain in pregnancy. Am. J. Obstet. Gynecol. 1996; 174: 254-258.
142. Ochsenbein-Kölble N, Roos M, Gasser T, Zimmermann R. Cross-sectional study of weight gain and increase in BMI throughout pregnancy. Europ. J. Obstet. Gynecol. 2007, 130: 180-186.
143. Oken E, Taveras EM, Kleinman KP, Rich-Edwards JW, Gillman MW. Gestational weight gain and child adiposity at age 3 years. Am. J. Obstet. Gynecol. 2007; 196: 322.e1-8.
144. Olson CM, Strawderman MS, Dennison BA. Maternal Weight Gain During Pregnancy and Child Weight at Age 3 Years. Matern. Child Health J. 2009; 13: 839-46.
145. Rasmussen KM, Yaktine AL (Eds); Committee to Reexamine IOM Pregnancy Weight Guidelines; Institute of Medicine; National Research Council. Weight Gain During Pregnancy: Reexamining the Guidelines. Washington, DC: National Academies Press; 2009.
146. Seligman LC, Duncan BB, Branchtein L, Gaio DS, Mengue SS, Schmidt MI: Obesity and gestational weight gain: cesarean delivery and labor complications. Rev. Saude Publica. 2006; 40: 457-465.
147. Straube S, Voigt M, Briese V, Schneider KT, Voigt M. Weight gain in pregnancy according to maternal height and weight. J. Perinat. Med. 2008; 36: 405-12.
148. Voigt M, Schneider KTM, Fusch Ch, Hesse V, Röhl S, Helmers C, Schücking B: Normwerte der Gewichtszunahme in der Schwangerschaft. Geburtsh Frauenheilk. 2004; 64: 53-58.
149. Voigt M, Straube S, Olbertz D, Häuser B, Schneider KT. Beziehungen zwischen Körpergewicht, Körperhöhe, Body-Mass-Index und der Gewichtszunahme von Frauen in der Schwangerschaft. Z. Geburtshilfe Neonatol. 2007; 211: 147-52.
150. Bhattacharya S, Campbell DM, Liston WA, Bhattacharya S. Effect of Body Mass Index on pregnancy outcomes in nulliparous women delivering singleton babies. BMC Public Health. 2007; 7: 168.
151. Driul L, Cacciaguerra G, Citossi A, Martina MD, Peressini L, Marchesoni D. Prepregnancy body mass index and adverse pregnancy outcomes. Arch. Gynecol. Obstet. 2008; 278: 23-6.
152. Ebbeling CB, Pawlak DB, Ludwig DS. Childhood obesity: public-health crisis, common sense cure. Lancet. 2002; 360: 473-482.
153. Hibbard JU, Gilbert S, Landon MB, Hauth JC, Leveno KJ, Spong CY, Varner MW, Caritis SN, Harper M, Wapner RJ, Sorokin Y, Miodovnik M, Carpenter M, Peaceman AM, O'Sullivan MJ, Sibai BM, Langer O, Thorp JM, Ramin SM, Mercer BM, Gabbe SG; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Trial of labor or repeat cesarean delivery in women with morbid obesity and previous cesarean delivery. Obstet. Gynecol. 2006; 108: 125-33.
154. Laraia BA, Siega-Riz AM, Dole N, London E. Pregravid weight is associated with prior dietary restraint and psychosocial factors during pregnancy. Obesity. (Silver Spring). 2009; 17: 550-8.
155. Pasquali R, Gambineri A. Metabolic effects of obesity on reproduction. Reprod. Biomed. Online. 2006; 12: 542-551.
156. Ray JG, Thompson MD, Vermeulen MJ, Meier C, Wyatt PR, Wong PY, Summers AM, Farrell SA, Cole DE. Metabolic syndrome features and risk of neural tube defects. BMC Pregnancy Childbirth. 2007; 7: 21.
157. Robinson HE, O'Connell CM, Joseph KS, McLeod NL. Maternal outcomes in pregnancies complicated by obesity. Obstet. Gynecol. 2005; 106: 1357-64.
158. Sebire NJ, Jolly M, Harris JP, Wadsworth J, Joffe M, Beard RW, Regan L, Robinson S. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int. J. Obes. Relat. Metab. Disord. 2001; 25: 1175-82.
159. Stothard KJ, Tennant PW, Bell R, Rankin J. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA. 2009; 301: 636-50.
160. Voigt M, Zygmunt M, Henrich W, Straube S, Carstensen M, Briese V. Analysis of Subgroup of Pregnant Women in Germany 16th Communication: Morbid Obesity: Pregnancy Risks, Birth Risks and Status of the Newborn. Geburtsh Frauenheilk. 2008a; 68: 794-800.
161. Voigt M, Straube S, Zygmunt M, Krafczyk B, Schneider KT, Briese V. Obesity and pregnancy-a risk profile. Z. Geburtshilfe Neonatol. 2008b; 212: 201-5.
162. Worrel J, Lane S. Impact of pseudotumor cerebri (idiopathic intracranial hypertension) in pregnancy: a case report. AANA J. 2007; 75: 199-204.
163. Garcia-Enguidanos A, Calle ME, Valero J, Luna S, Dominguez-Rojas V. Risk factors in miscarriage: a review. Eur. J. Obstet. Gynecol. Reprod. Biol. 2002; 102: 111-119.
164. Homburg R. Pregnancy complications in PCOS. Best Pract. Res. Clin. Endocrinol. Metab. 2006; 20: 281-292.
165. Maconochie N, Doyle P, Prior S, Simmons R. Risk factors for first trimester miscarriage--results from a UK-population-based case-control study. BJOG. 2007; 114: 170-186.
166. Metwally M, Ong KJ, Ledger WL, Li TC. Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence. Fertil Steril. 2008; 90: 714-26.
167. Savitz DA, Hertz-Pichiotto I, Poole C, Olshan AF. Epidemiologic measures of the course and outcome of pregnancy. Epidemiol. Rev. 2002; 24: 91-101.
168. Veleva Z, Tiitinen A, Vilska S, Hyden-Granskog C, Tomas C, Martikainen H, Tapanainen JS. High and low BMI increase the risk of miscarriage after IVF/ICSI and FET. Hum. Reprod. 2008; 23: 878-84.
169. Zammiti W, Miraoui N, Kallel C, Mercier E, Almawi WY, Mahjoub T. A case-control study on the association of idiopathic recurrent pregnancy loss with autoantibodies against beta2-glycoprotein I and annexin V. Reproduction. 2006; 131: 817-822.
170. Chu SY, Kim SY, Lau J, Schmid CH, Dietz PM, Callaghan WM, Curtis KM. Maternal obesity and risk of stillbirth: a metaanalysis. Am. J. Obstet. Gynecol. 2007; 197: 223-228.
171. Fretts RC. Etiology and prevention of stillbirth. Am J Obstet Gynecol. 2005; 193: 1923-35.
172. King JC. Maternal obesity, metabolism, and pregnancy outcomes. Annu. Rev. Nutr. 2006; 26: 271-291.
173. Kristensen J, Vestergaard M, Wisborg K, Kesmodel U, Secher NJ. Pre-pregnancy weight and the risk of stillbirth and neonatal death. BJOG. 2005; 112: 403-408.
174. Nohr EA, Bech BH, Davies MJ, Frydenberg M, Henriksen TB, Olsen J. Prepregnancy obesity and fetal death: a study within the Danish National Birth Cohort. Obstet. Gynecol. 2005; 106: 250-259.
175. Salihu HM, Dunlop AL, Hedayatzadeh M, Alio AP, Kirby RS, Alexander GR. Extreme obesity and risk of stillbirth among black and white gravidas. Obstet. Gynecol. 2007; 110: 552-557.
176. Smith GC, Fretts RC. Stillbirth. Lancet. 2007; 370: 1715-1725.
177. Stephansson O, Dickman PW, Johansson A, Cnattingius S. Maternal weight, pregnancy weight gain, and the risk of antepartum stillbirth. Am. J. Obstet. Gynecol. 2001; 184: 464-469.
178. Hibbard JU, Gilbert S, Landon MB, Hauth JC, Leveno KJ, Spong CY, Varner MW, Caritis SN, Harper M, Wapner RJ, Sorokin Y, Miodovnik M, Carpenter M, Peaceman AM, ÓSullivan MJ, Sibai BM, Langer O, Thorp JM, Ramin SM, Mercer BM, Gabbe SG. Trial of labor or repeat cesarean delivery in women with morbid obesity and previous cesarean delivery. Obstet. Gynecol. 2006; 108: 125-133.
179. Lieberman E. Risk factors for uterine rupture during a trial of labor after cesarean. Clin. Obstet. Gynecol. 2001; 44: 609-21.
180. Markowska A, Belloni AS, Rucinski M, Parenti AR, Nardelli GB, Drews K, Nussdorfer GG, Malendowicz LK. Leprin and leptin receptor expression in the myometrium and uterine myomas: Is leptin involved in tumor development? Int. J. Oncol. 2005; 27: 1505-1509.
181. Curry AE, Thorsen P, Drews C, Schendel D, Skogstrand K, Flanders WD, Hougaard D, Olsen J, Vogel I. First-trimester maternal plasma cytokine levels, pre-pregnancy body mass index, and spontaneous preterm delivery. Acta Obstet. Gynecol. Scand. 2009, 88: 332-342.
182. Driul L, Cacciaguerra G, Citossi A, Martina MD, Peressini L, Mrchesoni D. Prepregnancy body mass index and adverse pregnancy outcomes. Arch. Gynecol. Obstet. 2008; 278: 23-26.
183. Ehrenberg HM, Iams JD, Goldenberg RL, Newman RB, Weiner SI, Sibai BM, Caritis SN, Miodovnik M, Dombrowski MP. Maternal obesity, uterine activity, and the risk of spontaneous preterm birth. Obstet. Gynecol. 2009; 113: 48-52.
184. Hacini Afroukh N, Burguet A, Thiriez G, Muliu B, Bouthet MF, Abraham L, Boisselier P, villemonteix P, Bauer V, Lathelize J, Pierre F. Very preterm birth: should be interested in maternal pre-pregnancy body mass index? Arch. Pediatr. 2008; 15: 1068-1075.
185. Hoyme UB, Möller U, Saling E. Ergebnisse und mögliche Konsequenzen der Thüringer Frühgeburtenvermeidungsaktion 2000. Geburtsh Frauenheilk. 2002; 62: 257-63.
186. Joesoef MR, Hillier SL, Wiknjosastro G, Sumampouw H, Linnan M, Norojono W, Idajadi A, Utomo B. Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight. Am. J. Obstet. Gynecol. 1995; 173: 1527-31.
187. Kekki M, Kurki T, Pelkonen J, Kurkinen-Räty M, Cacciatore B, Paavonen J. Vaginal Clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial. Obstet. Gynecol. 2001; 97: 643-48.
188. Kurkinen-Räty M, Vuopala S, Koskela M, Kekki M, Kurki T, Paavonen J, Jouppila P. A randomised controlled trial of vaginal clindamycin for early pregancy bacterial vaginosis. BJOG. 2000; 107: 1427-32.
189. Lamont RF, Duncan SLB, Mandal D, Bassett P. Intravaginal Clindamycin to reduce preterm birth in women with abnormal genital tract flora. Obstet. Gynecol. 2003; 101: 516-22.
190. McDonald HM, Brocklehurst P, Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst. Rev. 2007; (1): CD000262.
191. Mastrobattista JM, Klebanoff MA, Carey JC, Hauth JC, Macpherson CA, Ernest J, Cotroneo M, Leveno KJ, Wapner R, Varner M, Iams JD, Moawad A, Sibai BM, Miodovnik M, Dombrowski M, O'Sullivan MJ, Vandorsten JP, Langer O; National Institute of Child Health and Human Development Maternal-Fetal Medicine Unit Networks. The effect of body mass index on therapeutic response to bacterial vaginosis in pregnancy. Am. J. Perinatol. 2008; 25: 233-237.
192. Newton ER. Chorioamnionitis and intraamniotic infection. Clin. Obstet. Gynecol. 1993; 36: 795-808.
193. Nohr EA, Yaeth M, Beck BH, Henriksen TB, Cnattingius S, Olsen J. Maternal obesity and neonatal mortality according to subtypes of preterm birth. Obstet Gynecol. 2007; 110: 1083-1090.
194. Okun N, Gronau KA, Hannah ME. Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy: a systematic review. Obstet Gynecol. 2005; 105: 857-868.
195. Salihu HM, Lynch O, Alio AP, Liu J. Obesity subtypes and risk of spontaneous versus medically indicated preterm births in singleton and twins. Am. J. Epidemiol. 2008; 168: 13-20.
196. Simhan HN, Krohn MA: First-trimester cervical inflammatory milieu and subsequent early preterm birth. Am. J. Obstet. Gynecol. 2009; 200: 377.e1-4.
197. Voigt M, Straube S, Zygmunt M, Krafczyk B, Schneider KT, Briese V. Obesity and pregnancy-a risk profile. Z. Geburtshilfe Neonatol. 2008; 212: 201-5.
198. Willemsen RH, Leunissen RW, Stijnen T, Hokken-Koelega AC. Prematurity is not associated with reduced insulin sensitivity in adulthood. J. Clin. Endocrinol. Metab. 2009; 94: 1695-700.
199. Zegers-Hochschild F, Nygren KG, Adamson GD, de Mouzon J, Lancaster P, Mansour R, Sullivan E. International Committee Monitoring Assisted Reproductive Technologies. The ICMART glossary on ART terminology. Hum. Reprod. 2006; 21:1968-70.
200. Adeney KL, Williams MA, Miller RS, Frederick IO, Soensen TK, Luthy DA. Risk of preeclampsia in relation to maternal history of migraine headaches. J. Matern. Fetal Neonatal. Med. 2005; 18: 167-172.
201. Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol. 2008; 112: 359-372.
202. Baumwell S, Karumanchi SA. Pre-eclampsia: clinical manifestations and molecular mechanisms. Nephron. Clin. Pract. 2007; 106: c72-81.
203. Bodnar LM, Catov JM, Klebanoff MA, Ness RB, Roberts JM. Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology. 2007; 18: 234-239.
204. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001; 20: IX-XIV.
205. Catov JM, Ness RB, Kip KE, Olsen J. Risk of early or severe pre-eclampsia related to pre-existing conditions. Int. J. Epidemiol. 2007; 36: 412-419.
206. Clapp JF. Long-Term outcome after exercising throughout pregnancy: fitness and cardiovascular risk. Am. J. Obstet. Gynecol. 2008; 199: e1-489.e6.
207. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005; 330: 565.
208. Enquobahrie DA, Sanchez SE, Muy-Rivera M, Qiu C, Zhang C, Austin MA, Williams MA. Hepatic lipase gene polymorphism, pre-pregnancy overweight status and risk of preeclampsia among Peruvian women. Gynecol. Endocrinol. 2005; 21: 211-217.
209. Flegal KM, Carioo MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among U.. adults, 1999-2000. JAMA. 2002; 288: 1723-1727.
210. Hay JE. Liver disease in pregnancy. Hepatology. 2008; 47: 1067-76.
211. Haram K, Gjelland K. Foetal growth retardation. Tidsskr. Nor. Laegeforen. 2007; 127: 2665-2659.
212. Harskamp RE, Zeemann GG. Preeclampsia at risk for remote cardiovascular disease. Am. J. Med. Sci. 2007; 334: 291-295.
213. Jouppila P. Postpartum haemorrhage. Curr. Opin. Obstet. Gynecol. 1995; 7: 446-450.
214. Kaaja R. Predictors and risk factors of pre-eclampsia. Minerva Ginecol. 2008; 60: 421-9.
215. Knight M, Nelson-Piercy C, Kurinczuk JJ, Spark P, Brocklehurst P, UK Obstretic Surveillance System. A prospective national study of acute fatty liver of pregnancy in the UK. Gut. 2008; 57: 951-956.
216. Lee NM, Brady CW. Liver disease in pregnancy. World J. Gastroenterol. 2009 28; 15: 897-906.
217. Leeners B, Rath W, Kuse S, Irawan C, Imthurn B, Neumaier-Wagner P. BMI: new aspects of a classical risk factor for hypertensive disorders in pregnancy. Clin. Sci. (Lond). 2006a; 111: 81-86.
218. Leeners B, Rath W, Kuse S, Irawan C, Neumaier-Wagner P. The significance of under-or overweight during childhood as a risk factor for hypertensive diseases in pregnancy. Early Hum. Dev. 2006b; 82: 663-668.
219. Martin JN Jr, Rose CH, Briery CM. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am. J. Obstet. Gynecol. 2006; 195: 914-34.
220. Martin JN Jr, Briery CM, Rose CH, Owens MT, Bofill JA, Files JC. Postpartum plasma exchange as adjunctive therapy for severe acute fatty liver of pregnancy. J. Clin. Apher. 2008; 23: 138-143.
221. Mjahed K, Charra B, Hamoudi D, Noun M, Barrou L. Acute fatty liver of pregnancy. Arch. Gynecol. Obstet. 2006; 274: 349-353.
222. Ness RB, Hubel CA. Risk for coronary artery disease and morbid preeclampsia: a commentary. Ann. Epidemiol. 2005; 15: 726-733.
223. O'Brien TE, Ray JG, Chan WS. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology. 2003; 14: 368-74.
224. Robinson HE, ÓConell CM, Joseph KS, McLeod NL. Maternal outcomes in pregnancies complicated by obesity. Obstet. Gynecol. 2005; 106: 1357-1364.
225. Villar J, Carroli G, Wojdyla D, Abalos E, Giordano D, Ba'aqeel H, Farnot U, Bergsjø P, Bakketeig L, Lumbiganon P, Campodónico L, Al-Mazrou Y, Lindheimer M, Kramer M; World Health Organization Antenatal Care Trial Research Group. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am. J. Obstet. Gynecol. 2006; 194: 921-31.
226. Zhang C, Williams MA, Edwards KL, Austin MA. Trp64Arg polymorphism of the beta3-adrenergic receptor gene, pre-pregnancy obesity and risk of pre-eclampsia. J. Matern. Fetal. Neonatal Med. 2005; 17: 19-28.
227. Chunihal SD, Bates SM. Venous thromboembolism in pregnancy: diagnosis, management and prevention. Thromb. Haemost. 2009; 101: 428-438.
228. Forestier F, Daffos F, Capella-Pavlovsky M. Low molecular weight Heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound. Thromb. Res. 1984; 34: 557-560.
229. Heit JA, Kobbervig CE, James AH. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann. Intern. Med. 2005; 143: 697-706.
230. James AH, Jamison MG, Brancazio LR, Myers MR. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am. J. Obstet. Gynec. 2006; 194: 1311-5.
231. Marik PE, Plante LA. Thromboembolic Disease and Pregnancy. N. Engl. J. Med. 2008; 359: 2025-33.
232. Meignan M, Rosso J, Gauthier H. Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis. Arch. Intern. Med. 2000; 160: 159-64.
233. Merhi Z, Awonuga A. Acute abdominal pain as the presenting symptom of isolated iliac vein thrombosis in pregnancy. Obstet. Gynec. 2006; 107: 468-70.
234. Robertson L, Wu O, Langhorne P. Thrombophilia in pregnancy: a systematic review. Br. J. Haemat. 2006; 132: 171-96.
235. Rutherford SE, Phelan JP. Thromboembolic disease in pregnancy. Clin. Perinat. 1986; 13: 719-739.
236. Berger H, Crane J, Farine D, Armson A, De La Ronde S, Keenan-Lindsay L, Leduc L, Reid G, Van Aerde J, Maternal-Fetal Medicine Committee; Executive and Council of the Society of Obstetricians and Gynecologists of Canada. Screening for gestational diabetes mellitus. J. Obstet. Gynaecol. Can. 2003; 24: 894-912.
237. Cheng YW, Caughey AB. Gestational diabetes: diagnosis and management. J. Perinatol. 2008; 28: 657-64.
238. Langer O, Yogev Y, Xenakis EM, Rosenn B. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. Am. J. Obstet. Gynecol. 2005; 192: 134-139.
239. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA. Hyperglycemia and adverse pregnancy outcomes. N. Engl. J. Med. 2008; 358: 1991-2002.
240. ÒSullivan JH. Diabetes mellitus after GDM. Diabetes. 1991; 40 Suppl 2: 131-135.
241. Ritterrath C, Siegmund T, Rad NT, Stein U, Buhling KJ. Accuracy and influence of ascorbic acid on glucose-test with urine dip sticks in prenatal care. J. Perinat. Med. 2006; 34: 285-288.
242. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP. Metformin versus insulin for the treatment of gestational diabetes. N. Engl. J. Med. 2008; 358: 2003-2015.
243. Seshiah V, Balaji V, Balaji MS, Paneerselvam A, Kapur A. Pregnancy and diabetes scenario around the world: India. Int. J. Gynaecol. Obstet. 2009; 104 Suppl 1: S35-8.
244. Simmons D, Rowan J, Reid R, Campbell N, National GDM Working Party. Screening, diagnosis and services for women with gestational diabetes mellitus (GDM) in New Zealand: a technical report from the National GDM Technical Working Party. N. Z. Med. J. 2008; 121: 74-86.
245. Voigt M, Straube S, Zygmunt M, Krafczyk B, Schneider KT, Briese V. Obesity and pregnancy-a risk profile. Z. Geburtshilfe Neonatol. 2008; 212: 201-5.
246. Aschkenazi S, Rochelson B, Bernasko J, Kaplan J. Insulin resistance complicating pregnancy in a human immunodeficiency virus infected patient treated with protease inhibitors and corticosteroids. Obstet. Gynecol. 2003; 102: 1210-1212.
247. Bader MS, Kelly DV. Diagnosis and management of common chronic metabolic complications in HIV-infected patients. Postgrad. Med. 2008; 120: 17-27.
248. Carroll MA, Yeomans ER. Diabetic ketoacidosis in pregnancy. Crit. Care Med. 2005; 33: (10 suppl): S347-353.
249. Chauhan SP, Perry KG. Management of diabetic ketoacidosis in the obstetric patient. Obstet. Gynecol. Clin. North Am. 1995; 22: 143-155.
250. Chico M, Levine SN, Lewis DF. Normoglycemic diabetic ketoacidosis in pregnancy. J. Perinatol. 2008; 28: 310-312.
251. Guo RX, Yang LZ, Li LX, Zhao XP. Diabetic ketoacidosis in pregnancy tends to occur at lower blood glucose levels: case-control study and a case report of euglycemic diabetic ketoacidosis in pregnancy. J. Obstet. Gynaecol. Res. 2008; 34: 324-330.
252. Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, Wall BM. Management of hyperglycemic crisis in patients with diabetes. Diabetes Care. 2001; 24: 131-153.
253. Moon SW, Hahm JR, Lee GW, Kang MY, Jung JH, Jung TS, Lee KW, Jung KA, Ahn YJ, Kim S, Kim MA, Kim DR, Chung SI, Park MH. A case of hyperglycemic hyperosmolar state associated with Graves' hyperthyroidism: A case report. J. Korean Med. Sci. 2006; 21: 765-767.
254. Parker JA, Conway DL. Diabetic ketoacidosis in pregnancy. Obstet. Gynecol. Clin. North Am. 2007; 34: 533-543.
255. Tarif N, Al Badr W. Euglycemic diabetic ketoacidosis in pregnancy. Saudi J. Kidney Dis. Transpl. 2007; 18: 590-593.
256. Ramin KD. Diabetic ketoacidosis in pregnancy. Obstet. Gynecol. Clin. North Am. 1999; 26: 481-488.
257. Schumacher A, Sidor J, Bühling KJ. Glukosemessung mit dem kontinuierlich messenden Glukosesensor CGMS® bei stoffwechselgesunden Schwangeren während Betamethasontherapie zur fetalen Lungenreifeinduktion. Z. Geburtshilfe Neonatol. 2006; 210: 184-190.
258. Wagner A, Risse A, Brill HL, Wienhausen-Wilke V, Rottmann M, Sondern K, Angelkort B. Therapy of severe diabetic ketoacidosis. Zero-mortality under very-low-dose insulin application. Diabetes Care. 1999; 674-677.
259. Garry D, Leikin E, Fleisher AG, Tejani N. Acute myocardial infarction in pregnancy with subsequent medical and surgical management. Obstet. Gynaecol. 1996; 87: 802-804.
260. Hankins GDV, Wendel GD, Leveno KJ, Stoneham J. Myocardial infarction during pregnancy: a review. Obstet. Gynecol. 1985; 65: 139-46.
261. James AH, Jamison MG, Biswas MS, Brancazio LR, Swamy GK, Myers ER. Acute myocardial infarction in pregnancy: a United States population-based study, Circulation. 2006; 113: 1564-1571.
262. Ladner HE, Danielson B, Gilbert WM. Acute myocardial infarction in pregnancy and the puerperium: a population-based study. Obstet. Gynecol. 2005; 105: 480-484.
263. McLintic AJ, Pringle SD, Lilley S, Houston AB, Thorburn J.Electrocardiographic changes during cesarean section under regional anesthesia. Anesth. Analg. 1992; 74: 51-6.
264. Pierre-Louis B, Singh P, Frishman WH. Acute inferior wall myocardial infarction and percutaneous coronary intervention of the right coronary during active labor: a clinical report and review of the literature. Cardiol. Rev. 2008; 16: 260-268.
265. Ray P, Murphy G, Shurt L. Recognition and management of maternal cardiac disease in pregnancy. Br. J. Anaesth. 2004; 93: 428-439.
266. Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy. J. Am. Coll. Cardiol. 2008; 52: 171-180.
267. Schumacher B, Belfort MA, Card RJ. Successful treatment of acute myocardial infarction during pregnancy with tissue plasminogen activator. Am. J. Obstet. Gynecol. 1997; 176: 716-719.
268. Zaidi AN, Raman SV, Cook SC. Acute myocardial infarction in early pregnancy: definition of myocardium at risk with noncontrast T2-weighted cardiac magnetic resonance. Am. J. Obstet. Gynecol. 2008: e9-e12.
269. Bateman BT, Schumacher HC, Bushnell CD, Pile-Spellman J, Simpson LL, Sacco RL, Berman MF. Intracerebral hemorrhage in pregnancy: frequency, risk factors, and outcome. Neurology. 2006; 3: 424-429.
270. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007; 335: 974.
271. Bushnell CD. Stroke in women: risk and prevention throughout the lifespan. Neurol. Clin. 2008; 26: 1161-1176.
272. ESHRE Capri Workshop Group. Hormones and cardiovascular health in women. Hum. Reprod. Update. 2006; 12: 483-97.
273. Gilbert WM, Young AL, Danielson B. Pregnancy outcomes in women with chronic hypertension: a population-based study. J. Reprod. Med. 2007; 52: 1046-1051.
274. Helms AK, Drogan O, Kittner SJ. First Trimester Stroke Prophylaxis in Pregnant Women With a History of Stroke. Stroke. 2009; 40: 1158-61.
275. James AH, Bushnell CD, Jamison MG, Myers ER. Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet. Gynecol. 2005; 106: 509-516.
276. Kittner SJ, Stern BJ, Feeser BR, Hebel R, Nagey DA, Buchholz DW, Earley CJ, Johnson CJ, Macko RF, Sloan MA, Wityk RJ, Wozniak MA. Pregnancy and the risk of stroke. N. Engl. J. Med. 1996; 335: 768-774.
277. Rexrode KM, Hennekens CH, Willett WC, Colditz GA, Stampfer MJ, Rich-Edwards JW, Speizer FE, Manson JE. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA. 1997; 277: 1539-45.
278. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T; American Heart Association/American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation. 2006; 113: e409-49.
279. Shah Q, Messé SR. Cervicocranial arterial dissection. Curr. Treat Options Neurol. 2007; 9: 55-62.
280. Sharshar T, Lamy C, Mas JL. Incidence and causes of strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de France. Stroke in Pregnancy Study Group. Stroke. 1995; 26: 930-6.
281. Aroori S, Spence R AJ. Carpal tunnel syndrome. Ulster Med. J. 2008; 77: 6-17.
282. McCabe SJ, Uebele AL, Pihur V, Rosales RS, Atroshi I. Epidemiologic associations of carpal tunnel syndrome and sleep position: Is there a case for causation? Hand. (N Y). 2007; 2: 127-34.
283. Padua L, Aprile I, Caliandro P, Carboni T, Meloni A, Massi S, Mazza O, Mondelli M, Morini A, Murasecco D, Romano M, Tonali P; Italian Carpal Tunnel Syndrome Study Group. Symptoms and neurophysiological picture of carpal tunnel syndrome in pregnancy. Clin. Neurophysiol. 2001; 112: 1946-51.
284. Sax TW, Rosenbaum RB. Neuromuscular disorders in pregnancy. Muscle Nerve. 2006; 34: 559-71.
285. Champagne K, Schwartzman K, Opatrny L, Barriga P, Morin L, Mallozzi A, Benjamin A, Kimoff RJ. Obstructive sleep apnoea and its association with gestational hypertension. Eur. Respir. J. 2009; 33: 559-65.
286. Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure. Hypertension. 2000; 35: 144-147.
287. Guilleminault C, Palombini L, Poyares D, Takaoka S, Huynh NT, El-Sayed Y. Pre-eclampsia and nasal CPAP: part 1. Early intervention with nasal CPAP in pregnant women with risk-factors for pre-eclampsia: preliminary findings. Sleep Med. 2007; 9: 9-14.
288. Huang QR, Qin Z, Zhang S, Chow CM. Clinical patterns of obstructive sleep apnea and its comorbid conditions: a data mining approach. J. Clin. Sleep Med. 2008; 4: 543-50.
289. Maasilta P, Bachour A, Teramo K, Polo O, Laitinen LA. Sleep-related disordered breathing during pregnancy in obese women. Chest. 2001; 120: 1448-54.
290. Schoenfeld A, Ovadia Y, Neri A, Freedman S. Obstructive sleep apnea (OSA)-implications in maternal-fetal medicine. A hypothesis. Med. Hypotheses. 1989; 30: 51-4.
291. Sharma SK, Kumpaeat S, Banga A, Goel A. Prevalence and risk factors of obstructive sleep apnoea syndrome in a population of Delhi, India. Chest. 2006; 130: 149-156.
292. Bartha I, Dinva T, Seres I, Paragh G, Ross C, Hayden MR, Biro S, Yaegha G. Acute hypertriglyceridemic pancreatitis during pregnancy due to homozygous lipoprotein lipase gene mutation. Clin. Chim. Acta. 2009; 400: 137-138.
293. Beattie GJ, Keay S, Muir BB, Boddy K. Acute pancreatitis with pseudocyst formation complicating pregnancy in a patient with a co-existent choledochal cyst. Br. J. Obstet. Gynaecol. 1993; 100: 957-959.
294. Debenedet AT, Raghunatan TE, Wing JJ, Wamsteker EJ, DiMagno MJ. Alcohol use and cigarette smoking as risk factors for post-endoscopic retrograde cholangiopancreato-graphy pancreatitis. Clin. Gastroenterol. Hepatol. 2009; 7: 353-8e4.
295. De Waele B, Vanmierlo B, Van Nieuwenhove Y, Delvaux G. Impact of body overweight and class I, II and III obesity on the outcome of acute biliary pancreatitis. Pancreas. 2006; 32: 343-5.
296. Fortson MR, Freedman SN, Webster PD. Clinical assessment of hyperlipidemic pancreatitis. Am. J. Gastroenterol. 1995; 90: 2134-2139.
297. Lowenfels AB, Maisonneuve P. Cause(s) of acute pancreatitis: smoke signals from Southern Sweden. Pancreatology. 2008; 8: 61-62.
298. Lowenfels AB, Maisonneuve P, Sullivan T. The changing character of acute pancreatitis: epidemiology, etiology, and prognosis. Curr. Gastroenterol. Rep. 2009; 11: 97-103.
299. Mahley RW. Biochemistry and physiology of lipid and lipoprotein metabolism. In: Becker KL. Principles and Practice of Endocrinology and Metabolism. Philadelphia. JB Lipincott; 1995. p. 1369-1378.
300. Okerberg K, Lee M. Spuriously normal amylase levels in a patient with acute pancreatitis secondary to hypertriglyceridemia. J. Am. Board Fam. Pract. 1999; 12: 68-70.
301. Pilot A, Nadler E, Cavallero E, Coquard JL, Jacotot B. Prevention of recurrent acute pancreatitis inpatients with severe hypertriglyceridemia: value of regular plasmapheresis. Pancreas. 1996; 13: 96-99.
302. Salem M, Fouda R, Fouda U, Maadawy ME, Ammar H: Rapunzel and pregnancy. South Med. J. 2009; 102: 106-107.
303. Sharma P, Lim S, James D, Orchard RT, Horne M, Seymour CA. Pancreatitis may occur with a normal amylase concentration in hypertriglyceridemia. BMJ. 1996; 313: 1265.
304. Sivakumaran P, Tabak SW, Gregory K, Pepkowitz SH, Klapper EB. Management of familial hypertriglyceridemia during pregnancy with plasma exchange. J. Clin. Apher. 2009; 24: 42-46.
305. Son HJ, Paik SW, Rhee PL, Kim JJ, Koh KC, Rhee JC. Acute pancreatitis complicating pregnancy in a patient with co-existing choledochal cyst. Korean J. Intern. Med. 1997; 12: 105-108.
306. Tang SJ, Mayo MJ, Rodriguez-Frias E, Armstrong L, Tang L, Sreenarasimhaiah J, Lara LF, Rockey DC. Safety and utility of ERCP during pregnancy. Gastrointest. Endosc. 2009; 69: 433-461.
307. Dzaja A, Wehrle R, Lancel M, Pollmächer T. Elevated estradiol plasma levels in women with restless legs during pregnancy. Sleep. 2009; 32: 169-174.
308. Gao X, Schwarzschild MA, Wang H, Ascherio A. Obesity and restless legs syndrome in men and women. Neurology. 2009; 72: 1255-1261.
309. Lee KA, Zaffke ME, Baratte-Beebe K. Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron. J. Womens Health Gend. Based Med. 2001; 10: 335-341.
310. Amir LH, Donath S. A systematic review of maternal obesity and breastfeeding intention, initiation and duration. BMC Pregnancy Childbirth. 2007; 7: 9.
311. Andersen J, Watt J, Olson J, Van Aerde J. Perinatal brachial plexus palsy. Paediatr. Child Health. 2006; 11: 93-100.
312. Andersson L, Sundström-Poromaa I, Wulff M, Aström M, Bixo M. Depression and anxiety during pregnancy and six months postpartum: a follow-up study. Acta Obstet. Gynecol. Scand. 2006;85:937-944.
313. Bhattacharya S, Campbell DM, Liston WA, Bhattacharya S. Effect of body mass index on pregnancy outcomes in nulliparous women delivering singleton babies. BMC Public Health. 2007;7:168
314. Doherty DA, Magann EF, Francis J, Morrison JC, Newnham JP. Pre-pregnancy body mass index and pregnancy outcomes. Int. J. Gynaecol. Obstet. 2006; 95: 242-247.
315. Gottlieb AG, Galan HL. Shoulder dystocia: an update. Obstet. Gynecol. Clin. North Am. 2007; 34: 501-531.
316. Hall LF, Neubert AG. Obesity and pregnancy. Obstet. Gynecol. Surv. 2005; 60: 253-360.
317. Heslehurst N, Simpson H, Ells LJ, Rankin J, Wilkinson J, Lang R, Brown TJ, Summerbell CD. The impact of maternal BMI status on pregnancy outcomes with immediate short-term obstetric resource implications: a meta-analysis. Obes. Rev. 2008; 9: 635-683.
318. Jevitt C, Hernandez I, Groër M. Lactation complicated by overweight and obesity: supporting the mother and newborn. J. Midwifery Womens Health. 2007; 52: 606-613.
319. Larsen TB, Sørensen HT, Gislum M, Johnsen SP. Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study. Thromb. Res. 2007; 120: 505-509.
320. Martinelli I. Thromboembolism in women. Semin. Thromb. Hemost. 2006; 32: 709-715.
321. Myles TD, Gooch J, Santolaya J. Obesity as an independent risk factor for infectious morbidity in patients who undergo cesarean delivery. Obstet. Gynecol. 2002; 100: 959-964.
322. Schroeder BM; American College of Obstetricians and Gynecologists. ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. American College of Obstetricians and Gynecologists. Am. Fam. Physician. 2002; 66: 330-1.
323. Stamilio DM, DeFranco E, Paré E, Odibo AO, Peipert JF, Allsworth JE, Stevens E, Macones GA. Short interpregnancy interval: risk of uterine rupture and complications of vaginal birth after cesarean delivery. Obstet. Gynecol. 2007; 110: 1075-1082.
324. Usha Kiran TS, Hemmadi S, Bethel J, Evans J. Outcome of pregnancy in a woman with an increased body mass index. BJOG. 2005; 112: 768-772.
325. Wacker JR, Wagner BK, Briese V, Schauf B, Heilmann L, Bartz C, Hopp H. Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil. Eur. J. Obstet. Gynecol. Reprod. Biol. 2006; 127: 160-5.
326. Wax JR, Cartin A, Wolff R, Lepich S, Pinette MG, Blackstone J. Pregnancy following gastric bypass surgery for morbid obesity: maternal and neonatal outcomes. Obes. Surg. 2008; 18: 540-544.
327. Balki M, Ronayne M, Davies S, Fallah S, Kingdom J, Windrim R, Carvalho JC. Minimum oxytocin dose requirement after cesarean delivery for labor arrest. Obstet. Gynecol. 2006; 107: 45-50.
328. Bolton TJ, Randall K, Yentis SM. Effect of the Confidential Enquiries into Maternal Death on the use of Syntocinon of caesarean section in the UK. Anaesthesia. 2003; 58: 277-279.
329. Borruto F, Treisser A, Comparetto C. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial. Arch. Gynecol. Obstet. 2009; 280: 707-12.
330. Carvalho JC, Balki M, Kingdom J, Windrim R. Oxytocin requirements at elective cesarean delivery: a dose-finding study. Obstet. Gynecol. 2004; 104: 1005-1010.
331. Nirmala K, Zainuddin AA, Ghani NA, Zulkifli S, Jamil MA. Carbetocin versus syntometrine in prevention of post-partum hemorrhage following vaginal delivery. J. Obstet. Gynaecol. Res. 2009; 35: 48-54.
332. Prendivielle WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labor. Cochrane Database Syst. Rev. 2000; (3): CD000007.
333. Sartain JB, Barry JJ, Howat PW, McCormack DI, Bryant M. Intravenous oxytocin bolus of 2 units is superior to 5 units during elective Caesarean section. Br. J. Anaesth. 2008; 101: 822-826.
334. Svanström MC, Biber B, Hanes M, Johansson G, Näslund U, Bålfors EM. Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during Caesarean section. Br. J. Anaesth. 2008; 100: 683-9.
335. Cooper GM, McClure JH. Anaesthesia chapter from saving mothers' lives; reviewing maternal deaths to make pregnancy safer. Br. J. Anaesth. 2008; 100: 17-22.
336. Dixit A, Girling JC. Obesity and pregnancy. J. Obstet. Gynaecol. 2008; 28:14-23.
337. Kuczkowski KM. Labor analgesia for the morbidly obese parturient: an old problem-new solution. Arch. Gynecol. Obstet. 2005; 271: 302-303.
338. Mychaskiw G 2nd, Panigrahi T, Ray T, Shah S. Intentional puncture of the dural space as an aid to epidural placement in a morbidly obese parturient. J. Miss. State Med. Assoc. 2001; 42: 303-305.
339. Nakanishi R, Nishimura S, Kimura M, Miyazaki Y, Hamada T, Mori T. Cesarean section in a morbidly obese parturient with borderline personality disorder under combined spinal and epidural anesthesia. Masui. 2008; 57: 628-630.
340. Nitta R, Yabe M, Sato M, Kimura T, Nishikawa T. Successful epidural anesthesia using 120 mm epidural needle for cesarean section in a morbidly obese parturient with body mass index 50.2 kg x m(-2). Masui. 2006; 55: 1409-1411.
341. Pan PH, Moore CH, Ross VH. Severe maternal bradycardia and asystole after combined spinal-epidural labor analgesia in a morbidly obese parturient. J. Clin. Anesth. 2004; 16: 461-464.
342. Ray A, Hildreth A, Esen UI. Morbid obesity and intra-partum care. J. Obstet. Gynaecol. 2008; 28: 301-304.
343. Reber A: [Airways and respiratory function in obese patients. Anaesthetic and intensive care aspects and recommendations]. Anaesthesist. 2005; 54: 715-725.
344. Reyes M, Pan PH. Very low-dose spinal anesthesia for cesarean section in a morbidly obese preeclamptic patient and its potential implications. Int. J. Obstet. Anesth. 2004; 13: 99-102.
345. Saravanakumar K, Rao SG, Cooper GM. Obesity and obstetric anaesthesia. Anaesthesia. 2006; 61: 36-48.
346. Shnaider R, Ezri T, Szmuk P, Larson S, Warters RD, Katz J. Combined spinal-epidural anesthesia for Cesarean section in a patient with peripartum dilated cardiomyopathy. Can. J. Anaesth. 2001; 48: 681-683.
347. Soens MA, Birnbach DJ, Ranasinghe JS, van Zundert A. Obstetric anesthesia for the obese and morbidly obese patient: an ounce of prevention is worth more than a pound of treatment. Acta Anaesthesiol. Scand. 2008; 52: 6-19.
348. Vallejo MC. Anesthetic management of the morbidly obese parturient. Curr. Opin. Anaesthesiol. 2007; 20: 175-180.
349. Whitty RJ, Maxwell CV, Carvalho JC. Complications of neuraxial anesthesia in an extreme morbidly obese patient for Cesarean section. Int. J. Obstet. Anesth. 2007; 16: 139-44.
350. Cohen JH, Kim H: Sociodemographic and health characteristics associated with attempting weight loss during pregnancy. Prev. Chronic Dis. 2009; 6(1): A07.
351. Dixit A, Girling JC. Obesity and pregnancy. J. Obstet. Gynaecol. 2008; 28: 14-23.
352. Institute of Medicine (IOM). Preventing childhood obesity: Health in the balance. Report 2004, http://www.iom.edu/?id=22623, accessed 17 March 2009
353. Karam JG, El-Sayegh S, Nessim F, Farag A, McFarlane ST. Medical management of obesity: an update. Minerva Endocrinol. 2007; 32: 185-207.
354. Turzansk Fortner R, Pekow P, Solomon CG, CG, Markenson G, Chasan-Taber L: Pregnancy body mass index, gestational weight gain, and risk of hypertensive pregnancy among Latina women. Am. J. Obstet. Gynecol. 2009; 200: 167. e1-167. e7.
355. Straube S, Voigt M, Briese V, Schneider KT, Voigt M. Weight gain in pregnancy according to maternal height and weight. J. Perinat. Med. 2008; 36: 405-12.
356. Voigt M, Straube S, Schmidt P, Pildner von Steinburg S, Schneider KT. [Standard values for the weight gain in pregnancy according to maternal height and weight] Z. Geburtshilfe Neonatol. 2007; 211: 191-203.